| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-cysteine methyltransferase activity | 1.32e-05 | 2 | 73 | 2 | GO:0106363 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NOLC1 CCDC88C SH3PXD2B SHANK2 SNAP91 CASKIN1 SH3KBP1 LRP2 CCDC6 RIMS2 SRRM2 | 3.18e-04 | 875 | 73 | 11 | GO:0019904 |
| GeneOntologyCellularComponent | Cajal body | 2.14e-04 | 84 | 73 | 4 | GO:0015030 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 4.26e-04 | 9 | 73 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 4.26e-04 | 9 | 73 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BICD2 NOLC1 SRRM1 TAF3 UTP18 SMARCA2 SMARCC1 KMT2A XRCC1 SRRM2 ZC3H3 ELL INO80E | 8.77e-04 | 1377 | 73 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | npBAF complex | 1.07e-03 | 14 | 73 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 1.07e-03 | 14 | 73 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 1.07e-03 | 14 | 73 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 1.40e-03 | 16 | 73 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.51e-03 | 141 | 73 | 4 | GO:0048786 | |
| Domain | NHS_fam | 1.42e-05 | 2 | 71 | 2 | IPR024845 | |
| Domain | NCKAP5_C | 1.42e-05 | 2 | 71 | 2 | IPR032769 | |
| Domain | Nckap5l | 1.42e-05 | 2 | 71 | 2 | IPR026163 | |
| Domain | NHS | 1.42e-05 | 2 | 71 | 2 | PF15273 | |
| Domain | NCKAP5 | 1.42e-05 | 2 | 71 | 2 | PF15246 | |
| Domain | SH3 | 1.78e-05 | 216 | 71 | 7 | SM00326 | |
| Domain | SH3 | 1.78e-05 | 216 | 71 | 7 | PS50002 | |
| Domain | SH3_2 | 1.89e-05 | 86 | 71 | 5 | IPR011511 | |
| Domain | SH3_2 | 1.89e-05 | 86 | 71 | 5 | PF07653 | |
| Domain | SH3_domain | 2.01e-05 | 220 | 71 | 7 | IPR001452 | |
| Domain | BROMODOMAIN_2 | 5.06e-04 | 41 | 71 | 3 | PS50014 | |
| Domain | BROMO | 5.43e-04 | 42 | 71 | 3 | SM00297 | |
| Domain | Bromodomain | 5.43e-04 | 42 | 71 | 3 | IPR001487 | |
| Domain | - | 5.43e-04 | 42 | 71 | 3 | 1.20.920.10 | |
| Domain | SAM_1 | 2.21e-03 | 68 | 71 | 3 | PF00536 | |
| Domain | Znf_FYVE_PHD | 2.38e-03 | 147 | 71 | 4 | IPR011011 | |
| Domain | SH3_1 | 3.53e-03 | 164 | 71 | 4 | PF00018 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MICALL1 KANSL3 BICD2 NOLC1 SRRM1 TAF3 UTP18 BRD2 SFSWAP RSL1D1 SMARCA2 OTUD4 SMARCC1 KMT2A CCDC6 SRRM2 PRRC2A | 6.03e-13 | 774 | 75 | 17 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MICALL1 NOLC1 CCDC88C NHSL1 SRRM1 SH3PXD2B PPFIBP1 ARHGEF1 KMT2A NHS RAI14 SRGAP2 CCDC6 SRRM2 WNK1 NCKAP5L AGAP3 | 3.27e-12 | 861 | 75 | 17 | 36931259 |
| Pubmed | KANSL3 NOLC1 TAF3 BRD2 ATAD5 RSL1D1 MYL6B SH3KBP1 SMARCA2 LRP2 OTUD4 SMARCC1 KMT2A C15orf39 RAI14 XRCC1 SRRM2 PRRC2A HP1BP3 INO80E | 1.53e-11 | 1429 | 75 | 20 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MICALL1 KANSL3 CCDC88C NHSL1 SH3PXD2B SHANK2 BRD2 PIK3CD SPEG CASKIN1 KSR2 C15orf39 ULK4 SRGAP2 WNK1 ELL IQCE AGAP3 | 1.64e-11 | 1105 | 75 | 18 | 35748872 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 SRRM1 TAF3 BRD2 SFSWAP SNAP91 ATAD5 RSL1D1 SMARCC1 KMT2A HMGN2 XRCC1 SRRM2 PRRC2A ELL HP1BP3 | 1.71e-10 | 954 | 75 | 16 | 36373674 |
| Pubmed | 5.03e-10 | 133 | 75 | 8 | 15144186 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 SRRM1 UTP18 BRD2 SFSWAP ATAD5 RSL1D1 SMARCA2 SMARCC1 KMT2A SPATS2 SRRM2 HP1BP3 | 5.55e-10 | 605 | 75 | 13 | 28977666 |
| Pubmed | BICD2 NOLC1 SRRM1 UTP18 RSL1D1 OTUD4 NHS CCDC6 SRRM2 WNK1 PRRC2A AGAP3 | 8.41e-10 | 503 | 75 | 12 | 16964243 | |
| Pubmed | 1.53e-09 | 153 | 75 | 8 | 10718198 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 SRRM1 TAF3 BRD2 ATAD5 MYL6B SMARCA2 SMARCC1 KMT2A XRCC1 SRRM2 HP1BP3 | 1.62e-09 | 533 | 75 | 12 | 30554943 |
| Pubmed | SHANK2 PIK3CD MAP4K5 SH3KBP1 LRP2 SMARCC1 HMGN2 NCKAP5 XRCC1 RIMS2 | 2.41e-09 | 329 | 75 | 10 | 17474147 | |
| Pubmed | 2.73e-09 | 57 | 75 | 6 | 21555454 | ||
| Pubmed | 2.73e-09 | 103 | 75 | 7 | 32744500 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MICALL1 NHSL1 SH3PXD2B SHANK2 RSL1D1 PPFIBP1 SH3KBP1 PARVA CRYBG1 NHS RAI14 SRGAP2 | 3.10e-09 | 565 | 75 | 12 | 25468996 |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 3.81e-09 | 108 | 75 | 7 | 19531213 | |
| Pubmed | 4.38e-09 | 255 | 75 | 9 | 15324660 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MICALL1 NOLC1 SRRM1 AKTIP SFSWAP RSL1D1 PPFIBP1 PARVA OTUD4 SMARCC1 RAI14 SRGAP2 XRCC1 CCDC6 SRRM2 ELL | 1.19e-08 | 1284 | 75 | 16 | 17353931 |
| Pubmed | NOLC1 SRRM1 TAF3 BRD2 SFSWAP ATAD5 PIK3R2 SMARCA2 LRP2 SMARCC1 SRRM2 NCKAP5L ZC3H3 AGAP3 INO80E | 1.35e-08 | 1116 | 75 | 15 | 31753913 | |
| Pubmed | CCDC88C SH3PXD2B SHANK2 SNAP91 CASKIN1 SH3KBP1 KSR2 TPPP OTUD4 SMARCC1 SRGAP2 SPATS2 CCDC6 PRRC2A | 1.66e-08 | 963 | 75 | 14 | 28671696 | |
| Pubmed | NOLC1 GARIN5B SRRM1 UTP18 SHANK2 BRD2 ABI3BP SNAP91 RSL1D1 SMARCC1 KMT2A HMGN2 USPL1 RIMS2 SH3D21 HP1BP3 | 5.95e-08 | 1442 | 75 | 16 | 35575683 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KANSL3 NOLC1 SRRM1 UTP18 BRD2 SFSWAP ATAD5 RSL1D1 SMARCC1 KMT2A HMGN2 XRCC1 SRRM2 HP1BP3 INO80E | 9.37e-08 | 1294 | 75 | 15 | 30804502 |
| Pubmed | SHANK2 BRD2 SFSWAP ATAD5 PPFIBP1 SMARCA2 OTUD4 KMT2A CRYBG1 RAI14 SRGAP2 XRCC1 SPATS2 PRRC2A AGAP3 INO80E | 9.92e-08 | 1497 | 75 | 16 | 31527615 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.63e-07 | 186 | 75 | 7 | 33637726 | |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 1.86e-07 | 59 | 75 | 5 | 16083285 | |
| Pubmed | KANSL3 SRRM1 TAF3 SFSWAP RSL1D1 MYL6B OTUD4 SMARCC1 KMT2A HMGN2 RAI14 SPATS2 PRRC2A HP1BP3 INO80E | 1.97e-07 | 1371 | 75 | 15 | 36244648 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | BICD2 NOLC1 UTP18 SHANK2 ARHGEF1 OTUD4 C15orf39 CRYBG1 SPATS2 CCDC6 WNK1 NCKAP5L HP1BP3 | 3.16e-07 | 1038 | 75 | 13 | 26673895 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MICALL1 BICD2 SH3PXD2B ATAD5 RSL1D1 OTUD4 SMARCC1 SRGAP2 SPATS2 PRRC2A INO80E | 4.31e-07 | 724 | 75 | 11 | 36232890 |
| Pubmed | SRRM1 PIK3R2 ARHGEF1 MYL6B SH3KBP1 SMARCC1 KMT2A SRGAP2 CCDC6 PRRC2A HP1BP3 AGAP3 | 5.91e-07 | 916 | 75 | 12 | 32203420 | |
| Pubmed | SRRM1 BRD2 RSL1D1 ARHGEF1 MYL6B PARVA OTUD4 KMT2A RAI14 HP1BP3 | 6.67e-07 | 601 | 75 | 10 | 33658012 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.04e-07 | 231 | 75 | 7 | 16452087 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | KANSL3 NOLC1 SRRM1 TAF3 UTP18 RSL1D1 ARHGEF1 SMARCA2 SMARCC1 KMT2A CRYBG1 HMGN2 SRRM2 HP1BP3 | 7.59e-07 | 1318 | 75 | 14 | 30463901 |
| Pubmed | 8.55e-07 | 347 | 75 | 8 | 17114649 | ||
| Pubmed | NOLC1 SRRM1 UTP18 SFSWAP RSL1D1 PPFIBP1 HMGN2 RAI14 IQCE HP1BP3 AGAP3 | 8.61e-07 | 777 | 75 | 11 | 35844135 | |
| Pubmed | 1.12e-06 | 360 | 75 | 8 | 33111431 | ||
| Pubmed | 1.15e-06 | 156 | 75 | 6 | 22952844 | ||
| Pubmed | 1.23e-06 | 251 | 75 | 7 | 31076518 | ||
| Pubmed | NOLC1 SRRM1 UTP18 RSL1D1 SMARCA2 SMARCC1 KMT2A SRRM2 PRRC2A HP1BP3 | 1.41e-06 | 653 | 75 | 10 | 22586326 | |
| Pubmed | KANSL3 NOLC1 SRRM1 TAF3 BRD2 ATAD5 SMARCA2 SMARCC1 KMT2A HMGN2 XRCC1 HP1BP3 | 1.71e-06 | 1014 | 75 | 12 | 32416067 | |
| Pubmed | NHSL1 SHANK2 SNAP91 ARHGEF1 CASKIN1 SH3KBP1 TPPP OTUD4 KMT2A RAI14 SRGAP2 PRRC2A HP1BP3 AGAP3 | 2.00e-06 | 1431 | 75 | 14 | 37142655 | |
| Pubmed | 2.41e-06 | 399 | 75 | 8 | 35987950 | ||
| Pubmed | MICALL1 NOLC1 SRRM1 UTP18 BRD2 ATAD5 RSL1D1 MAP4K5 PPFIBP1 PIK3R2 SEMA6A SRRM2 NCKAP5L HP1BP3 | 3.12e-06 | 1487 | 75 | 14 | 33957083 | |
| Pubmed | 3.58e-06 | 421 | 75 | 8 | 36976175 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 15466011 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10668804 | ||
| Pubmed | 5.47e-06 | 446 | 75 | 8 | 24255178 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.47e-06 | 608 | 75 | 9 | 36089195 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 SRRM1 RSL1D1 PPFIBP1 ARHGEF1 PARVA SMARCC1 SRGAP2 SPATS2 SRRM2 WNK1 PRRC2A HP1BP3 | 9.56e-06 | 1415 | 75 | 13 | 28515276 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PPFIBP1 MYL6B SMARCC1 KMT2A SRGAP2 CCDC6 SRRM2 PRRC2A HP1BP3 | 9.63e-06 | 639 | 75 | 9 | 23443559 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.02e-05 | 486 | 75 | 8 | 30940648 | |
| Pubmed | 1.04e-05 | 645 | 75 | 9 | 25281560 | ||
| Pubmed | 1.10e-05 | 491 | 75 | 8 | 36273042 | ||
| Pubmed | 1.16e-05 | 233 | 75 | 6 | 37704626 | ||
| Pubmed | 1.25e-05 | 21 | 75 | 3 | 12453419 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 23079975 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 10995463 | ||
| Pubmed | Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins. | 1.37e-05 | 3 | 75 | 2 | 31727973 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 27240832 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 35077478 | ||
| Pubmed | SRRM1 SFSWAP RSL1D1 KMT2A RAI14 SPATS2 SRRM2 PRRC2A ELL HP1BP3 | 1.38e-05 | 847 | 75 | 10 | 35850772 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MICALL1 BICD2 CCDC88C AKTIP SH3PXD2B PPFIBP1 MYL6B LRP2 NCKAP5L ELL | 1.47e-05 | 853 | 75 | 10 | 28718761 |
| Pubmed | NHSL1 BRD2 ATAD5 OTUD4 NHS RAI14 XRCC1 CCDC6 SRRM2 NCKAP5L PRRC2A | 1.50e-05 | 1049 | 75 | 11 | 27880917 | |
| Pubmed | BICD2 BRD2 RSL1D1 PPFIBP1 LRP2 RAI14 NCKAP5 SRGAP2 CCDC6 USPL1 PRRC2A AGAP3 | 1.87e-05 | 1285 | 75 | 12 | 35914814 | |
| Pubmed | NOLC1 SH3PXD2B RSL1D1 PIK3CD ARHGEF1 LRP2 OTUD4 SMARCC1 CRYBG1 SRGAP2 WNK1 | 2.03e-05 | 1084 | 75 | 11 | 11544199 | |
| Pubmed | KANSL3 NOLC1 RSL1D1 SMARCA2 SMARCC1 KMT2A C15orf39 HMGN2 XRCC1 SRRM2 PRRC2A | 2.38e-05 | 1103 | 75 | 11 | 34189442 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NOLC1 SRRM1 BRD2 MAP4K5 PPFIBP1 PIK3R2 RIN2 PARVA KMT2A CCDC6 | 2.55e-05 | 910 | 75 | 10 | 36736316 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.55e-05 | 268 | 75 | 6 | 33024031 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 10908574 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 27616589 | ||
| Pubmed | Mitotic inactivation of a human SWI/SNF chromatin remodeling complex. | 2.75e-05 | 4 | 75 | 2 | 9744861 | |
| Pubmed | The PI3K p110delta controls T-cell development, differentiation and regulation. | 2.75e-05 | 4 | 75 | 2 | 17371229 | |
| Pubmed | Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation. | 2.75e-05 | 4 | 75 | 2 | 24421395 | |
| Pubmed | The super elongation complex (SEC) family in transcriptional control. | 2.75e-05 | 4 | 75 | 2 | 22895430 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 16452305 | ||
| Pubmed | 2.78e-05 | 731 | 75 | 9 | 29298432 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.82e-05 | 163 | 75 | 5 | 22113938 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 ATAD5 RSL1D1 KMT2A HMGN2 RAI14 SRGAP2 WNK1 PRRC2A HP1BP3 | 3.18e-05 | 934 | 75 | 10 | 33916271 |
| Pubmed | 3.38e-05 | 29 | 75 | 3 | 36800290 | ||
| Pubmed | 3.38e-05 | 29 | 75 | 3 | 19279220 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 SRRM1 UTP18 RSL1D1 MYL6B HMGN2 RAI14 XRCC1 SRRM2 HP1BP3 | 3.64e-05 | 949 | 75 | 10 | 36574265 |
| Pubmed | Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). | 4.57e-05 | 5 | 75 | 2 | 9843504 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 20200404 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 27435003 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 16086288 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 24413172 | ||
| Pubmed | 4.75e-05 | 441 | 75 | 7 | 31239290 | ||
| Pubmed | 4.89e-05 | 183 | 75 | 5 | 36129980 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | BICD2 UTP18 SMARCA2 OTUD4 CCDC6 USPL1 SRRM2 PRRC2A ELL INO80E | 5.88e-05 | 1005 | 75 | 10 | 19615732 |
| Pubmed | 6.00e-05 | 35 | 75 | 3 | 32504627 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 6.16e-05 | 626 | 75 | 8 | 33644029 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 6.38e-05 | 316 | 75 | 6 | 31665637 | |
| Pubmed | 6.73e-05 | 634 | 75 | 8 | 34591612 | ||
| Pubmed | A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. | 6.84e-05 | 6 | 75 | 2 | 10619021 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 16940996 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 9531537 | ||
| Pubmed | Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. | 6.84e-05 | 6 | 75 | 2 | 10949031 | |
| Pubmed | The emerging mechanisms of isoform-specific PI3K signalling. | 6.84e-05 | 6 | 75 | 2 | 20379207 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 16230384 | ||
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 15314177 | ||
| Pubmed | NOLC1 SRRM1 PIK3R2 SMARCA2 OTUD4 SMARCC1 NHS RAI14 SPATS2 SRRM2 PRRC2A | 7.20e-05 | 1247 | 75 | 11 | 27684187 | |
| Pubmed | 8.72e-05 | 486 | 75 | 7 | 20936779 | ||
| Interaction | BRD3 interactions | NOLC1 SRRM1 TAF3 BRD2 SFSWAP ATAD5 MYL6B SMARCA2 SMARCC1 KMT2A HMGN2 XRCC1 SRRM2 HP1BP3 AGAP3 INO80E | 1.95e-11 | 494 | 73 | 16 | int:BRD3 |
| Interaction | YWHAH interactions | MICALL1 NOLC1 CCDC88C NHSL1 SRRM1 SH3PXD2B SFSWAP PPFIBP1 SPEG DENND2C KSR2 KMT2A NHS RAI14 SRGAP2 CCDC6 RIMS2 SRRM2 WNK1 NCKAP5L AGAP3 | 1.84e-10 | 1102 | 73 | 21 | int:YWHAH |
| Interaction | YWHAG interactions | MICALL1 NOLC1 CCDC88C NHSL1 SRRM1 MAP4K5 PPFIBP1 SPEG ARHGEF1 DENND2C KSR2 KMT2A NHS RAI14 SRGAP2 CCDC6 SRRM2 WNK1 NCKAP5L AGAP3 | 1.08e-08 | 1248 | 73 | 20 | int:YWHAG |
| Interaction | TOP3B interactions | MICALL1 KANSL3 CCDC88C NHSL1 SH3PXD2B SHANK2 BRD2 PIK3CD SPEG CASKIN1 KSR2 OTUD4 C15orf39 ULK4 HMGN2 SRGAP2 WNK1 PRRC2A ELL IQCE AGAP3 | 3.15e-08 | 1470 | 73 | 21 | int:TOP3B |
| Interaction | YWHAB interactions | MICALL1 CCDC88C NHSL1 PPFIBP1 PIK3R2 SPEG DENND2C KSR2 KMT2A NHS RAI14 SRGAP2 CCDC6 SRRM2 WNK1 NCKAP5L AGAP3 | 9.12e-08 | 1014 | 73 | 17 | int:YWHAB |
| Interaction | BRD2 interactions | NOLC1 SRRM1 TAF3 BRD2 ATAD5 SMARCA2 SMARCC1 XRCC1 ZC3H3 HP1BP3 INO80E | 3.89e-07 | 429 | 73 | 11 | int:BRD2 |
| Interaction | H2BC4 interactions | 3.94e-07 | 259 | 73 | 9 | int:H2BC4 | |
| Interaction | SMC5 interactions | NOLC1 SRRM1 TAF3 BRD2 SFSWAP SNAP91 ATAD5 RSL1D1 SMARCC1 KMT2A HMGN2 XRCC1 SRRM2 PRRC2A ELL HP1BP3 | 4.38e-07 | 1000 | 73 | 16 | int:SMC5 |
| Interaction | YWHAE interactions | MICALL1 NOLC1 CCDC88C PPFIBP1 PIK3R2 KSR2 KMT2A NHS RAI14 SRGAP2 CCDC6 RIMS2 SRRM2 WNK1 NCKAP5L PRRC2A AGAP3 | 1.83e-06 | 1256 | 73 | 17 | int:YWHAE |
| Interaction | YWHAQ interactions | NOLC1 CCDC88C NHSL1 PPFIBP1 PIK3R2 SPEG DENND2C KSR2 KMT2A NHS ULK4 RAI14 SRGAP2 CCDC6 WNK1 NCKAP5L | 1.91e-06 | 1118 | 73 | 16 | int:YWHAQ |
| Interaction | TAF6 interactions | 2.90e-06 | 245 | 73 | 8 | int:TAF6 | |
| Interaction | CDH1 interactions | MICALL1 NHSL1 SH3PXD2B SHANK2 RSL1D1 PPFIBP1 SH3KBP1 PARVA CRYBG1 NHS RAI14 SRGAP2 DNMT3A | 3.37e-06 | 768 | 73 | 13 | int:CDH1 |
| Interaction | YWHAZ interactions | MICALL1 NOLC1 CCDC88C NHSL1 PPFIBP1 PIK3R2 SPEG KSR2 OTUD4 KMT2A NHS RAI14 SRGAP2 CCDC6 WNK1 NCKAP5L PRRC2A | 3.56e-06 | 1319 | 73 | 17 | int:YWHAZ |
| Interaction | BRD9 interactions | 4.17e-06 | 117 | 73 | 6 | int:BRD9 | |
| Interaction | ZNF330 interactions | NOLC1 TAF3 BRD2 ATAD5 RSL1D1 SMARCC1 KMT2A XRCC1 HP1BP3 DNMT3A | 4.56e-06 | 446 | 73 | 10 | int:ZNF330 |
| Interaction | DENND2D interactions | 8.55e-06 | 36 | 73 | 4 | int:DENND2D | |
| Interaction | CENPA interactions | 8.62e-06 | 377 | 73 | 9 | int:CENPA | |
| Interaction | LYN interactions | MICALL1 CCDC88C BRD2 MAP4K5 PPFIBP1 PIK3R2 DENND2C SH3KBP1 KMT2A RAI14 RIMS2 SRRM2 | 9.83e-06 | 720 | 73 | 12 | int:LYN |
| Interaction | POLR1G interactions | 1.02e-05 | 489 | 73 | 10 | int:POLR1G | |
| Interaction | CD2AP interactions | 1.24e-05 | 214 | 73 | 7 | int:CD2AP | |
| Interaction | BRD7 interactions | NOLC1 SRRM1 SH3PXD2B UTP18 BRD2 RSL1D1 PIK3R2 SMARCA2 SMARCC1 SRRM2 PRRC2A | 1.73e-05 | 637 | 73 | 11 | int:BRD7 |
| Interaction | SH3KBP1 interactions | 1.81e-05 | 315 | 73 | 8 | int:SH3KBP1 | |
| Interaction | H2BC12 interactions | 2.12e-05 | 322 | 73 | 8 | int:H2BC12 | |
| Interaction | ZCCHC10 interactions | 2.33e-05 | 236 | 73 | 7 | int:ZCCHC10 | |
| Interaction | LINC02910 interactions | 2.44e-05 | 95 | 73 | 5 | int:LINC02910 | |
| Interaction | NIFK interactions | 2.49e-05 | 431 | 73 | 9 | int:NIFK | |
| Interaction | RHOQ interactions | MICALL1 RSL1D1 PPFIBP1 PIK3R2 PARVA LRP2 RAI14 SEMA6A SRGAP2 | 3.03e-05 | 442 | 73 | 9 | int:RHOQ |
| Interaction | CSNK2A1 interactions | NOLC1 SRRM1 UTP18 BRD2 ATAD5 RSL1D1 SH3KBP1 KMT2A SRGAP2 XRCC1 CCDC6 SRRM2 HP1BP3 | 3.47e-05 | 956 | 73 | 13 | int:CSNK2A1 |
| Interaction | H2BC21 interactions | BICD2 BRD2 ATAD5 SMARCC1 KMT2A CRYBG1 HMGN2 XRCC1 SRRM2 PRRC2A HP1BP3 | 3.90e-05 | 696 | 73 | 11 | int:H2BC21 |
| Interaction | NCK2 interactions | 4.54e-05 | 262 | 73 | 7 | int:NCK2 | |
| Interaction | GRK5 interactions | 5.15e-05 | 182 | 73 | 6 | int:GRK5 | |
| Interaction | RABEP1 interactions | 5.47e-05 | 184 | 73 | 6 | int:RABEP1 | |
| Interaction | PARP1 interactions | MICALL1 NOLC1 SRRM1 TAF3 UTP18 BRD2 ATAD5 RSL1D1 SMARCA2 OTUD4 SMARCC1 HMGN2 XRCC1 HP1BP3 DNMT3A | 6.19e-05 | 1316 | 73 | 15 | int:PARP1 |
| Interaction | CHD3 interactions | NOLC1 SRRM1 BRD2 SFSWAP ATAD5 RSL1D1 SMARCA2 SMARCC1 KMT2A SPATS2 HP1BP3 | 8.31e-05 | 757 | 73 | 11 | int:CHD3 |
| Interaction | TCP10L3 interactions | 8.74e-05 | 24 | 73 | 3 | int:TCP10L3 | |
| Interaction | H1-1 interactions | 8.74e-05 | 507 | 73 | 9 | int:H1-1 | |
| Interaction | H3C1 interactions | GARIN5B TAF3 BRD2 ATAD5 RSL1D1 SMARCA2 KMT2A HMGN2 XRCC1 CCDC6 HP1BP3 DNMT3A | 8.80e-05 | 901 | 73 | 12 | int:H3C1 |
| Interaction | FGFR1 interactions | MICALL1 NHSL1 SH3PXD2B SNAP91 MAP4K5 PPFIBP1 PIK3R2 SH3KBP1 RAI14 SRGAP2 | 8.98e-05 | 632 | 73 | 10 | int:FGFR1 |
| Interaction | RNF138 interactions | 9.08e-05 | 125 | 73 | 5 | int:RNF138 | |
| Interaction | BAZ1B interactions | 9.68e-05 | 204 | 73 | 6 | int:BAZ1B | |
| Interaction | DNAJC9 interactions | 9.77e-05 | 296 | 73 | 7 | int:DNAJC9 | |
| Interaction | H2BC13 interactions | 1.13e-04 | 210 | 73 | 6 | int:H2BC13 | |
| Interaction | H1-4 interactions | BICD2 NOLC1 UTP18 BRD2 RSL1D1 TPPP KMT2A HMGN2 SPATS2 HP1BP3 | 1.22e-04 | 656 | 73 | 10 | int:H1-4 |
| Interaction | H1-2 interactions | BICD2 SRRM1 BRD2 RSL1D1 MAP4K5 KMT2A HMGN2 ZC3H3 IQCE HP1BP3 | 1.38e-04 | 666 | 73 | 10 | int:H1-2 |
| Interaction | NCKAP1 interactions | 1.39e-04 | 218 | 73 | 6 | int:NCKAP1 | |
| Interaction | KLF16 interactions | 1.49e-04 | 425 | 73 | 8 | int:KLF16 | |
| Interaction | TERF2IP interactions | 1.66e-04 | 552 | 73 | 9 | int:TERF2IP | |
| Interaction | PRC1 interactions | BICD2 NOLC1 SRRM1 UTP18 BRD2 RSL1D1 MYL6B SH3KBP1 HMGN2 RAI14 SRRM2 HP1BP3 | 1.81e-04 | 973 | 73 | 12 | int:PRC1 |
| Interaction | EFTUD2 interactions | NOLC1 SRRM1 AKTIP RSL1D1 PPFIBP1 ARHGEF1 PARVA SMARCA2 SMARCC1 SRGAP2 SPATS2 SRRM2 WNK1 PRRC2A HP1BP3 | 1.81e-04 | 1449 | 73 | 15 | int:EFTUD2 |
| Interaction | RHOB interactions | MICALL1 CCDC88C RSL1D1 MAP4K5 PPFIBP1 PIK3R2 ARHGEF1 MYL6B DENND2C RAI14 NCKAP5L | 2.07e-04 | 840 | 73 | 11 | int:RHOB |
| Interaction | NCKAP5 interactions | 2.10e-04 | 32 | 73 | 3 | int:NCKAP5 | |
| Interaction | BRDT interactions | 2.13e-04 | 81 | 73 | 4 | int:BRDT | |
| Interaction | IFI16 interactions | SRRM1 UTP18 RSL1D1 OTUD4 SMARCC1 RAI14 SPATS2 SRRM2 PRRC2A HP1BP3 | 2.42e-04 | 714 | 73 | 10 | int:IFI16 |
| Interaction | RAD18 interactions | 2.43e-04 | 457 | 73 | 8 | int:RAD18 | |
| Interaction | ASF1A interactions | 2.86e-04 | 249 | 73 | 6 | int:ASF1A | |
| Interaction | TFPT interactions | 2.88e-04 | 160 | 73 | 5 | int:TFPT | |
| Interaction | SIRT7 interactions | NOLC1 SRRM1 UTP18 RSL1D1 SMARCA2 SMARCC1 KMT2A SRRM2 PRRC2A HP1BP3 | 3.36e-04 | 744 | 73 | 10 | int:SIRT7 |
| Interaction | SRRM3 interactions | 3.57e-04 | 8 | 73 | 2 | int:SRRM3 | |
| Interaction | MYCN interactions | NOLC1 SRRM1 UTP18 SFSWAP RSL1D1 MYL6B SMARCA2 SMARCC1 KMT2A SPATS2 SRRM2 PRRC2A HP1BP3 DNMT3A | 3.60e-04 | 1373 | 73 | 14 | int:MYCN |
| Interaction | ZMYND11 interactions | 3.78e-04 | 94 | 73 | 4 | int:ZMYND11 | |
| Interaction | TMSB4Y interactions | 3.79e-04 | 39 | 73 | 3 | int:TMSB4Y | |
| Interaction | EGR2 interactions | 3.91e-04 | 171 | 73 | 5 | int:EGR2 | |
| Interaction | NUP43 interactions | 4.15e-04 | 625 | 73 | 9 | int:NUP43 | |
| Interaction | KCTD13 interactions | NHSL1 SHANK2 SNAP91 ARHGEF1 CASKIN1 SH3KBP1 TPPP OTUD4 KMT2A RAI14 SRGAP2 PRRC2A HP1BP3 AGAP3 | 4.19e-04 | 1394 | 73 | 14 | int:KCTD13 |
| Interaction | DNAJC5 interactions | 4.35e-04 | 378 | 73 | 7 | int:DNAJC5 | |
| Interaction | DCAF4 interactions | 4.35e-04 | 378 | 73 | 7 | int:DCAF4 | |
| Interaction | ALDH1A2 interactions | 4.40e-04 | 41 | 73 | 3 | int:ALDH1A2 | |
| Interaction | NR2C2 interactions | KANSL3 NOLC1 SRRM1 TAF3 UTP18 RSL1D1 ARHGEF1 SMARCA2 SMARCC1 KMT2A CRYBG1 HMGN2 SRRM2 HP1BP3 | 4.47e-04 | 1403 | 73 | 14 | int:NR2C2 |
| Interaction | H2BC1 interactions | 4.70e-04 | 178 | 73 | 5 | int:H2BC1 | |
| Interaction | H2AC4 interactions | 4.80e-04 | 506 | 73 | 8 | int:H2AC4 | |
| Interaction | PPP3CA interactions | 4.82e-04 | 179 | 73 | 5 | int:PPP3CA | |
| Interaction | H2BC18 interactions | 4.94e-04 | 180 | 73 | 5 | int:H2BC18 | |
| Interaction | ZFP36 interactions | 5.07e-04 | 181 | 73 | 5 | int:ZFP36 | |
| Interaction | NSD2 interactions | 5.13e-04 | 278 | 73 | 6 | int:NSD2 | |
| Interaction | CHD4 interactions | NOLC1 SRRM1 UTP18 BRD2 SFSWAP RSL1D1 SMARCA2 SMARCC1 KMT2A SRRM2 HP1BP3 | 5.29e-04 | 938 | 73 | 11 | int:CHD4 |
| Interaction | TNRC6A interactions | 5.32e-04 | 280 | 73 | 6 | int:TNRC6A | |
| Interaction | CSDE1 interactions | 5.73e-04 | 284 | 73 | 6 | int:CSDE1 | |
| Interaction | ACE2 interactions | MICALL1 UTP18 SHANK2 BRD2 ABI3BP RSL1D1 C15orf39 HMGN2 RAI14 XRCC1 SRRM2 HP1BP3 | 5.80e-04 | 1106 | 73 | 12 | int:ACE2 |
| Interaction | APEX1 interactions | NOLC1 SRRM1 BRD2 ATAD5 RSL1D1 ARHGEF1 RIN2 SMARCC1 KMT2A HMGN2 XRCC1 PRRC2A HP1BP3 | 5.84e-04 | 1271 | 73 | 13 | int:APEX1 |
| Interaction | TANC1 interactions | 5.95e-04 | 106 | 73 | 4 | int:TANC1 | |
| Interaction | TAF10 interactions | 6.17e-04 | 107 | 73 | 4 | int:TAF10 | |
| Interaction | CIT interactions | NOLC1 SRRM1 UTP18 RSL1D1 MYL6B SMARCA2 SMARCC1 KMT2A HMGN2 RAI14 XRCC1 SRRM2 PRRC2A HP1BP3 | 6.22e-04 | 1450 | 73 | 14 | int:CIT |
| Interaction | DOT1L interactions | SRRM1 SFSWAP RSL1D1 KMT2A RAI14 SRGAP2 SRRM2 PRRC2A ELL HP1BP3 | 6.35e-04 | 807 | 73 | 10 | int:DOT1L |
| Interaction | ARHGAP27 interactions | 6.97e-04 | 11 | 73 | 2 | int:ARHGAP27 | |
| Interaction | GATA4 interactions | 7.14e-04 | 411 | 73 | 7 | int:GATA4 | |
| Interaction | SSRP1 interactions | 8.00e-04 | 685 | 73 | 9 | int:SSRP1 | |
| Interaction | SAP18 interactions | 8.32e-04 | 305 | 73 | 6 | int:SAP18 | |
| Interaction | SFN interactions | 8.59e-04 | 692 | 73 | 9 | int:SFN | |
| Interaction | RCBTB2 interactions | 8.87e-04 | 52 | 73 | 3 | int:RCBTB2 | |
| Interaction | CAMKV interactions | 8.90e-04 | 118 | 73 | 4 | int:CAMKV | |
| Interaction | C11orf52 interactions | 9.20e-04 | 311 | 73 | 6 | int:C11orf52 | |
| Interaction | FOS interactions | 9.36e-04 | 312 | 73 | 6 | int:FOS | |
| Interaction | UQCR11 interactions | 9.38e-04 | 53 | 73 | 3 | int:UQCR11 | |
| Interaction | FGFRL1 interactions | 9.38e-04 | 53 | 73 | 3 | int:FGFRL1 | |
| Interaction | MAGEA9 interactions | 9.49e-04 | 208 | 73 | 5 | int:MAGEA9 | |
| Interaction | GJD4 interactions | 9.84e-04 | 13 | 73 | 2 | int:GJD4 | |
| Interaction | DPM2 interactions | 9.91e-04 | 54 | 73 | 3 | int:DPM2 | |
| Interaction | MLLT1 interactions | 1.04e-03 | 123 | 73 | 4 | int:MLLT1 | |
| Interaction | BCL7A interactions | 1.04e-03 | 123 | 73 | 4 | int:BCL7A | |
| Interaction | SORBS1 interactions | 1.04e-03 | 123 | 73 | 4 | int:SORBS1 | |
| GeneFamily | Ankyrin repeat domain containing | 2.34e-04 | 242 | 42 | 5 | 403 | |
| GeneFamily | Sterile alpha motif domain containing | 1.12e-03 | 88 | 42 | 3 | 760 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 2.98e-06 | 417 | 75 | 9 | M39224 | |
| Coexpression | GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN | 8.86e-06 | 168 | 75 | 6 | M13844 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | CCDC88C SHANK2 SNAP91 PIK3R2 SPEG MYL6B KSR2 SMARCC1 NCKAP5 ZBTB12 XRCC1 CCDC6 NCKAP5L PRRC2A INO80E | 3.30e-05 | 1275 | 75 | 15 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | BICD2 NOLC1 GARIN5B BRD2 SFSWAP ARHGEF1 NYNRIN SH3KBP1 SMARCC1 RAI14 ZBTB12 PRRC2A | 3.75e-05 | 844 | 75 | 12 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.12e-05 | 362 | 75 | 8 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | BICD2 NOLC1 GARIN5B ARHGEF1 NYNRIN SH3KBP1 OTUD4 ZBTB12 PRRC2A | 9.37e-05 | 524 | 75 | 9 | gudmap_developingGonad_e12.5_testes_k1_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#4 | 1.30e-04 | 73 | 75 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | BICD2 NOLC1 GARIN5B BRD2 SFSWAP ARHGEF1 NYNRIN SH3KBP1 OTUD4 ZBTB12 PRRC2A | 1.35e-04 | 819 | 75 | 11 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | BICD2 NOLC1 BRD2 SFSWAP ARHGEF1 NYNRIN LRP2 SMARCC1 RAI14 ZBTB12 PRRC2A | 1.74e-04 | 843 | 75 | 11 | gudmap_developingGonad_e11.5_testes_1000 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.32e-07 | 170 | 75 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.77e-06 | 161 | 75 | 5 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-06 | 162 | 75 | 5 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-05 | 178 | 75 | 5 | d3a75a8082e70543b84c35d53fe77625300d19fa | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-05 | 178 | 75 | 5 | b2cda1df801b1a1a41e3dd2808baef37765cd804 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 180 | 75 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 182 | 75 | 5 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 183 | 75 | 5 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-05 | 185 | 75 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 186 | 75 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 187 | 75 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 187 | 75 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 187 | 75 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.64e-05 | 188 | 75 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.69e-05 | 189 | 75 | 5 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 189 | 75 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 190 | 75 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 191 | 75 | 5 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 191 | 75 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 191 | 75 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 191 | 75 | 5 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 75 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 1.96e-05 | 195 | 75 | 5 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.96e-05 | 195 | 75 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 196 | 75 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.01e-05 | 196 | 75 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 2.01e-05 | 196 | 75 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 198 | 75 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 198 | 75 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 198 | 75 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.11e-05 | 198 | 75 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 198 | 75 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 2.16e-05 | 199 | 75 | 5 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.21e-05 | 200 | 75 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 123 | 75 | 4 | 87401764a073c1808f214642a9c84299c78f7ec7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 158 | 75 | 4 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 158 | 75 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 158 | 75 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 162 | 75 | 4 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.61e-04 | 162 | 75 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 163 | 75 | 4 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 164 | 75 | 4 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 167 | 75 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 168 | 75 | 4 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 169 | 75 | 4 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 170 | 75 | 4 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | TCGA-Prostate-Solid_Tissue_Normal-Prostate_normal_tissue-Prostate_normal_tissue-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.98e-04 | 171 | 75 | 4 | cafcb7714110cb361808dbe4b9a4963bb71f5129 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-04 | 172 | 75 | 4 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.03e-04 | 172 | 75 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 173 | 75 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 173 | 75 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.12e-04 | 174 | 75 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 75 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-04 | 178 | 75 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-04 | 179 | 75 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 179 | 75 | 4 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 2.36e-04 | 179 | 75 | 4 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 179 | 75 | 4 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 179 | 75 | 4 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 180 | 75 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-04 | 180 | 75 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 180 | 75 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 180 | 75 | 4 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 181 | 75 | 4 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.52e-04 | 182 | 75 | 4 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.52e-04 | 182 | 75 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.57e-04 | 183 | 75 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 184 | 75 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 184 | 75 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 2.62e-04 | 184 | 75 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-04 | 184 | 75 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-04 | 185 | 75 | 4 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 185 | 75 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.68e-04 | 185 | 75 | 4 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 185 | 75 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 185 | 75 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 185 | 75 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 185 | 75 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 2.73e-04 | 186 | 75 | 4 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 186 | 75 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.79e-04 | 187 | 75 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.79e-04 | 187 | 75 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-04 | 188 | 75 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-04 | 188 | 75 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 188 | 75 | 4 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-04 | 189 | 75 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 189 | 75 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 189 | 75 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 189 | 75 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 190 | 75 | 4 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.96e-04 | 190 | 75 | 4 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 190 | 75 | 4 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.79e-06 | 187 | 75 | 7 | 4323_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.10e-06 | 190 | 75 | 7 | 4306_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.21e-06 | 191 | 75 | 7 | 7435_DN | |
| Drug | 2-azido-ATP | 2.26e-05 | 17 | 75 | 3 | CID000123645 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.56e-05 | 187 | 75 | 6 | 4302_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.78e-05 | 189 | 75 | 6 | 4271_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.13e-05 | 192 | 75 | 6 | 4104_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.25e-05 | 193 | 75 | 6 | 6981_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 4.38e-05 | 194 | 75 | 6 | 7044_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 4123_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 1314_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 4.77e-05 | 197 | 75 | 6 | 484_UP | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 3414_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 4654_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 1502_UP | |
| Disease | contact dermatitis (is_implicated_in) | 6.37e-06 | 2 | 75 | 2 | DOID:2773 (is_implicated_in) | |
| Disease | lysophosphatidylcholine 16:0 measurement | 3.81e-05 | 4 | 75 | 2 | EFO_0010357 | |
| Disease | neuroimaging measurement | CCDC88C NHSL1 SNAP91 ARHGEF1 KSR2 SMARCA2 NCKAP5 MYO16 HP1BP3 AGAP3 INO80E | 7.86e-05 | 1069 | 75 | 11 | EFO_0004346 |
| Disease | hydrocephalus (is_implicated_in) | 9.50e-05 | 6 | 75 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | cortical thickness | MICALL1 NHSL1 SH3PXD2B SNAP91 PPFIBP1 KMT2A NCKAP5 SRGAP2 ELL MYO16 AGAP3 | 1.12e-04 | 1113 | 75 | 11 | EFO_0004840 |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.42e-04 | 195 | 75 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.27e-04 | 9 | 75 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | monoclonal gammopathy | 3.37e-04 | 53 | 75 | 3 | EFO_0000203 | |
| Disease | red blood cell density measurement | 3.87e-04 | 880 | 75 | 9 | EFO_0007978 | |
| Disease | putamen volume change measurement | 4.88e-04 | 13 | 75 | 2 | EFO_0021495 | |
| Disease | drug use measurement, depressive symptom measurement, SSRI use measurement | 4.88e-04 | 13 | 75 | 2 | EFO_0007006, EFO_0007010, EFO_0007011 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 6.55e-04 | 15 | 75 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | platelet component distribution width | 6.60e-04 | 755 | 75 | 8 | EFO_0007984 | |
| Disease | FEV/FEC ratio | 1.07e-03 | 1228 | 75 | 10 | EFO_0004713 | |
| Disease | triacylglycerol 52:6 measurement | 1.84e-03 | 25 | 75 | 2 | EFO_0010418 | |
| Disease | unipolar depression, depressive symptom measurement | 1.99e-03 | 26 | 75 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Acute monocytic leukemia | 1.99e-03 | 26 | 75 | 2 | C0023465 | |
| Disease | cortical surface area measurement | BICD2 CCDC88C NHSL1 PIK3CD PPFIBP1 NCKAP5 SEMA6A PRRC2A MYO16 AGAP3 | 2.10e-03 | 1345 | 75 | 10 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKLDPPPSPHSNRKK | 531 | Q96P47 | |
| RKVPPPSPKSSGPKR | 1216 | Q96QE3 | |
| PSPKSSGPKRALPPK | 1221 | Q96QE3 | |
| SLKVPAPASRPKPRP | 761 | Q92888 | |
| PSRPHGSPSRSKPKK | 436 | P55199 | |
| KTSTPKKEGLAPPSP | 316 | Q8TD16 | |
| AAYAPPPPAKKPRKS | 446 | Q9Y6K1 | |
| PPPAKKPRKSTAEKP | 451 | Q9Y6K1 | |
| TKKPPSGKRPPILAP | 161 | Q8IUX7 | |
| PPRTAPKKQLPSIPK | 31 | Q9H8T0 | |
| SPTPASQSPKKPPAK | 881 | O60641 | |
| RSNSPDKFKRPTPPP | 416 | Q16204 | |
| ARPLPKKAPPKAKTP | 491 | Q5SSJ5 | |
| RSGTPKKRKAPPPPI | 266 | Q9P0K7 | |
| KKRKAPPPPISPTQL | 271 | Q9P0K7 | |
| SAPPPKKSLGTQPPK | 296 | Q14978 | |
| NPSKPIKAPSALPPR | 366 | Q01804 | |
| HKPPPTSPKSPYLSK | 36 | Q6IPM2 | |
| RKKGPPPPPPKRSSS | 941 | Q8WXD9 | |
| PKCLKVLPPSSTKPP | 281 | P15529 | |
| SKNLPKTKPPRLDPP | 1141 | Q9HCH0 | |
| SPFQIPPPSPDSKKK | 571 | Q86W92 | |
| PPPKPKRDPNTRLSA | 1296 | Q9Y6X6 | |
| KKNKLKPPGTPPPSS | 281 | Q6VAB6 | |
| ARLSAKPAPPKPEPK | 26 | P05204 | |
| PAAAPAARTKPKAPP | 1931 | Q9P219 | |
| KAKKPPLPPSRTDSL | 671 | Q5SYE7 | |
| SPSRKPPPISKKPKL | 1191 | Q5SYE7 | |
| SPKTKKRPAPRAPSA | 471 | Q8N3F8 | |
| SPSLPAKPKPPSRRD | 4616 | P98164 | |
| KLSDTPAPKRKRSPP | 86 | Q8NBZ0 | |
| SVRPPPPKPHKSKKG | 521 | Q9UQ26 | |
| ALPPKPPKAKPASTV | 301 | O00459 | |
| RPTASKPPALKNPPK | 161 | Q711Q0 | |
| GLEPSSKKKPPSPRP | 61 | A4D1S0 | |
| SKKKPPSPRPGSPRV | 66 | A4D1S0 | |
| PGKSEPPSKRPLSSK | 1156 | Q4ZHG4 | |
| LPPAKSAFKAPKLPP | 341 | Q68D51 | |
| PSSPLPGSKTSKRPK | 631 | Q9P2N6 | |
| DPAPKKSSSEPPPRK | 1251 | Q03164 | |
| ASPSVPGPTKPKPKT | 3526 | Q03164 | |
| KQPPPASSPTKRKGR | 96 | Q9Y4K1 | |
| KSTSKRAIPPPLPPK | 381 | Q9Y4K4 | |
| PVAKTSPAGPKTPKA | 631 | Q9P2P1 | |
| SPGRSKSPKSPKSPK | 311 | Q5VWG9 | |
| KPAPSSQRKPPARPS | 41 | Q9Y5J1 | |
| KPPDRPSSKSKDPPR | 736 | Q12872 | |
| RPHSPSRSPSPKKPL | 516 | A6NNA2 | |
| KPASPKKPPPGERRS | 2661 | Q9UQ35 | |
| PPAEKLSPNPPKLTK | 1371 | P51531 | |
| PSSKKIPAPDKVPSP | 256 | A4FU49 | |
| PPKVSPKRGVPKTSP | 1036 | O14513 | |
| SFRKPKAKPTPPKRS | 841 | Q6T4R5 | |
| RAVSALKPPSPPKSP | 536 | Q17RQ9 | |
| PRLPKASPKATSKPK | 1506 | Q9NTG1 | |
| KKPRPPKTNSLSRPG | 401 | Q96B97 | |
| SPPAKSLAPKKPPTG | 1186 | P48634 | |
| QKSPSVPKSPTPKSP | 6 | Q9NVD7 | |
| VPKSPTPKSPPSRKK | 11 | Q9NVD7 | |
| PPPPTPTESRKKSGK | 331 | Q92922 | |
| KKAPPPPKRAPTTAL | 731 | Q9UPX8 | |
| PKKATKTAPPALPTG | 616 | P25440 | |
| SPAPKVRKPGRKPPT | 956 | Q6ZRI6 | |
| TKPTPIPPPRLKKQA | 351 | Q8WYP3 | |
| PPTPSFKKGLPQRKP | 521 | Q86XZ4 | |
| RKSASKPPPISKPPA | 816 | Q5W0Q7 | |
| DPEPKPRKPATSSKP | 356 | Q8IXZ2 | |
| KSLLPPARTPKPAPK | 151 | Q9Y330 | |
| KPAGPSISKPAAKPA | 11 | P14649 | |
| SSPARPSAPKPSTPK | 2176 | Q15772 | |
| PKAPRANSALTPPKP | 446 | Q9BW04 | |
| KSPAKSPNPSTPRGK | 391 | O76021 | |
| RPPPPKKTSSSSRPL | 761 | A1X283 | |
| KRTPSLKPDVPPKPS | 1001 | Q9H2E6 | |
| PKKPPKRTSSPPRKT | 371 | Q8IYB3 | |
| VKKAKSPTPSPSPPR | 786 | Q8IYB3 | |
| AAPVKPPATRPKPTV | 1031 | O75044 | |
| AKPPPIPAKKPSSVS | 301 | O00329 | |
| KAKASKPTTPPENRP | 136 | M5A8F1 | |
| KPAKAANRTPPKSPG | 6 | O94811 | |
| SPSVPKRPKLPAPTR | 266 | P18887 | |
| KPGTAPSKPPLTKAP | 1746 | Q9H4A3 | |
| APKQTPRAPPKPKTS | 526 | Q7Z7G0 | |
| PLPPIPKDSSRPKAS | 236 | Q96C45 | |
| SPTAPKKKSLLLPAP | 521 | Q8N5Q1 |